Funding will support the company to achieve first-in-human data Oxford, UK, 8th April 2021 – Oxford Endovascular, a pioneering British MedTech company […]
Press Release: Oxford, UK, 14th November 2020. Oxford Endovascular Ltd, the developer of advanced neurovascular technologies to save lives of patients […]
Following extensive due diligence by medical, industry, and investor experts, Oxford Endovascular is selected as one of Europe’s top start-ups to be […]
This kick starts the company’s next fundraise to take it to first in human clinical data. See the RESI landing page for […]
‘Next Generation Flow Diverter for the Treatment of Intracranial Aneurysms Delivering Improved Patient Outcomes and Healthcare Cost Savings — OXIFLOW’ This project […]
The Birth of Oxford Endovascular – Interview with Beth Suzanne.
Oxford Endovascular kick starts its next fund raise following strong pre-clinical results
Oxford Endovascular in GLP phase with its brain aneurysm treatment device Oxford Endovascular Limited CEO Mike Karim spoke with Proactive Investors at […]
Oxford Endovascular, a spin-out from Oxford University, has used ‘origami engineering for the brain’ to develop a unique, patented, next-generation flow-diverter (OxiFlow) […]
On Monday, November 12th at 1600, Oxford Endovascular appeared live on ‘The Series A Hour with Match Capital’. This second series of […]
